A dose-finding phase II study of TAS-108

Trial Profile

A dose-finding phase II study of TAS-108

Phase of Trial: Phase II

Latest Information Update: 23 May 2016

At a glance

  • Drugs SR 16234 (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 02 Oct 2012 New source identified and integrated.
    • 01 Sep 2012 Results published in Cancer Science.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top